These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16454692)

  • 21. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
    Poulin P
    J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges.
    Schadt S; Hauri S; Lopes F; Edelmann MR; Staack RF; Villaseñor R; Kettenberger H; Roth AB; Schuler F; Richter WF; Funk C
    Drug Metab Dispos; 2019 Dec; 47(12):1443-1456. PubMed ID: 31748266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translating Pharmacokinetic and Pharmacodynamic Data into Practice.
    Visser M
    Vet Clin North Am Exot Anim Pract; 2018 May; 21(2):169-182. PubMed ID: 29655465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics in infants and children. A reappraisal.
    Kearns GL; Reed MD
    Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concept of Pharmacologic Target-Mediated Drug Disposition in Large-Molecule and Small-Molecule Compounds.
    An G
    J Clin Pharmacol; 2020 Feb; 60(2):149-163. PubMed ID: 31793004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of quantitative structure-pharmacokinetic relationships.
    Mayer JM; van de Waterbeemd H
    Environ Health Perspect; 1985 Sep; 61():295-306. PubMed ID: 3905378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic aspects of biotechnology products.
    Tang L; Persky AM; Hochhaus G; Meibohm B
    J Pharm Sci; 2004 Sep; 93(9):2184-204. PubMed ID: 15295780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of real-time PCR to pharmacokinetic studies].
    Wyska E; Rosiak M
    Postepy Hig Med Dosw (Online); 2006; 60():660-6. PubMed ID: 17245316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters.
    Smit C; De Hoogd S; Brüggemann RJM; Knibbe CAJ
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):275-285. PubMed ID: 29431542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug tissue distribution: study methods and therapeutic implications.
    Lanao JM; Fraile MA
    Curr Pharm Des; 2005; 11(29):3829-45. PubMed ID: 16305514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intestinal absorption and renal excretion mediated by transporters and the relationship with drug-drug interaction].
    Zhang J; Liu KX
    Yao Xue Xue Bao; 2010 Sep; 45(9):1089-94. PubMed ID: 21351563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of drug delivery.
    Robinson DS
    Curr Med Res Opin; 1983; 8 Suppl 2():10-9. PubMed ID: 6851621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interactions and clinical pharmacokinetics.
    Kristensen MB
    Clin Pharmacokinet; 1976; 1(5):351-72. PubMed ID: 797504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics in renal failure.
    Nancarrow C; Mather LE
    Anaesth Intensive Care; 1983 Nov; 11(4):350-60. PubMed ID: 6359952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.
    Hochman JH; Yamazaki M; Ohe T; Lin JH
    Curr Drug Metab; 2002 Jun; 3(3):257-73. PubMed ID: 12083320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
    Kearns GL
    Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.